Dysregulation of human beta-defensin-3 expression in the peripheral blood of patients with sepsis.
Noura Al MansourGhada Al-KafajiAli Al MahmeedKhalid M BindaynaPublished in: SAGE open medicine (2021)
This is the first study to show the downregulation of human beta-defensin-3 gene expression and protein level in sepsis, which may contribute to the complex immunological imbalance in sepsis. The significant correlation between human beta-defensin-3 mRNA expression and protein concentration suggests that mRNA expression could be used to predict protein level. Our study also showed a potential role of human beta-defensin-3 as a blood-based biomarker for sepsis. More studies on the clinical significance of human beta-defensin-3 in sepsis could further support a biomarker development.